Stockreport

PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent [MarketWatch]

PhaseBio Pharmaceuticals, Inc.  (PHAS) 
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am Check Earnings Report
PDF PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent Shares of PhaseBio Pharmaceuticals Inc. PHAS, +12.73% more than d [Read more]